Skip to main content
Premium Trial:

Request an Annual Quote

What If I Already Spent That $2,500 On New Lab Equipment?

A Wall Street Journal article looks at the pros and cons of direct-to-consumer genetic tests, such as Health Compass, a test offered by San Francisco Bay Area-based Navigenics and available early next year. Despite the fact that these tests can help predict disease susceptibility, some criticisms of include skepticism about their scientific accuracy, high prices (Navigenics is charging $2,500 for their test), insurance, and privacy issues. "Besides questions about accuracy, there is also the issue of how useful the answers will be," writes the WSJ. "There’s no evidence, many physicians say, that people will act on such information to lead healthier lives."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.